John Yeakel, M., Aarthi Kannan, B., Nicole Hook Rattigan, P., Maki Yamamoto, M., Alexey Aleshin, M., Jeremy P. Harris, M., MD, & Ling Gao, M. (2021). Bespoke circulating tumor DNA as a biomarker for treatment response in a refractory Merkel cell carcinoma patient. Elsevier.
Chicago Style (17th ed.) CitationJohn Yeakel, MD, BA Aarthi Kannan, PhD Nicole Hook Rattigan, MD Maki Yamamoto, MD Alexey Aleshin, MPhil Jeremy P. Harris, MD, and MD Ling Gao. Bespoke Circulating Tumor DNA as a Biomarker for Treatment Response in a Refractory Merkel Cell Carcinoma Patient. Elsevier, 2021.
MLA (8th ed.) CitationJohn Yeakel, MD, et al. Bespoke Circulating Tumor DNA as a Biomarker for Treatment Response in a Refractory Merkel Cell Carcinoma Patient. Elsevier, 2021.
Warning: These citations may not always be 100% accurate.